CLASS II ONGOING Device recall · Reported 5 Jun 2024 · FDA Enforcement Report

Tri-Staple 2.0 Black Reinforced Intelligent Reload recalled by Covidien

Covidien is recalling Tri-Staple 2.0 Black Reinforced Intelligent Reload- Applications in abdominal, distributed nationwide in the US. The recall was initiated on 15 Apr 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN: 10884521717633 20884521717630 Lot #: N3G1372Y
Quantity recalled1681 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1891-2024
FDA event ID
94484
Recalling firm
Covidien, North Haven, CT
Classification
Class II
Status
Ongoing
Recall initiated
15 Apr 2024
FDA classified
24 May 2024
Reported
5 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Apr 2024Recall initiated by company
24 May 2024Classified by FDA+39 days
5 Jun 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential damage to the cartridge can result in poor staple formation and/or incomplete staple line, may cause a delay in surgery

Product as listed by the FDA

Tri-Staple 2.0 Black Reinforced Intelligent Reload- Applications in abdominal, gynecologic, pediatric and thoracic surgery for resection, transection of tissue and creation of anastomosis Model: SIGTRSB60AXT

Where it was distributed

Worldwide - US Nationwide distribution in the state of NJ and the countries of Australia, Japan, New Zealand, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand.

Nationwide New Jersey

Questions about this recall

Why was it recalled?

Potential damage to the cartridge can result in poor staple formation and/or incomplete staple line, may cause a delay in surgery

Which lots are affected?

GTIN: 10884521717633 20884521717630 Lot #: N3G1372Y

Where was it sold?

Worldwide - US Nationwide distribution in the state of NJ and the countries of Australia, Japan, New Zealand, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Covidien

All 493

Other Other Medical Devices recalls

All 13,778